Literature DB >> 1905636

Identification of a new mutation responsible for hepatoerythropoietic porphyria.

M Romana1, B Grandchamp, A Dubart, S Amselem, C Chabret, Y Nordmann, M Goossens, P H Romeo.   

Abstract

A deficiency in the activity of uroporphyrinogen decarboxylase (URO-D), the fifth enzyme of the haem biosynthetic pathway, is found in two hereditary diseases, familial porphyria cutanea tarda (PCT) and hepatoerythropoietic porphyria (HEP). Little is known about the genetic relationship between those two diseases and it has been postulated that HEP is the homozygous form of PCT. A URO-D cDNA was cloned from an HEP patient and the comparison between the mutant and the wild-type sequences showed a single base difference within the coding sequence leading to the replacement of a glutamic acid by a lysine at codon 167 of the mutant protein. This replacement produced a protein which is rapidly degraded in the presence of cell lysate. On the basis of hybridization of synthetic oligomers to amplified genomic DNA, we demonstrated that this patient is homozygous for this single base mutation. In order to look for any relationship between HEP and PCT, we tested six unrelated patients with familial PCT and could not detect the codon 167 mutation in any of them. These results indicate an heterogeneity in the mutations responsible for the PCT and HEP phenotypes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1905636     DOI: 10.1111/j.1365-2362.1991.tb01814.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation.

Authors:  Julie L Cantatore-Francis; Jessica Cohen-Pfeffer; Manisha Balwani; Philip Kahn; Herbert M Lazarus; Robert J Desnick; Julie V Schaffer
Journal:  Arch Dermatol       Date:  2010-05

2.  Crystal structure of human uroporphyrinogen decarboxylase.

Authors:  F G Whitby; J D Phillips; J P Kushner; C P Hill
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

3.  Characterization of a new mutation (R292G) and a deletion at the human uroporphyrinogen decarboxylase locus in two patients with hepatoerythropoietic porphyria.

Authors:  H de Verneuil; F Bourgeois; F de Rooij; P D Siersema; J H Wilson; B Grandchamp; Y Nordmann
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

4.  Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping.

Authors:  C Wu; W Xu; C A Kozak; R J Desnick
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

Review 5.  Uroporphyrinogen decarboxylase.

Authors:  G H Elder; A G Roberts
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

6.  Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.

Authors:  M Mendez; L Sorkin; M V Rossetti; K H Astrin; A M del C Batlle; V E Parera; G Aizencang; R J Desnick
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.

Authors:  M J Moran-Jimenez; C Ged; M Romana; R Enriquez De Salamanca; A Taïeb; G Topi; L D'Alessandro; H de Verneuil
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  Molecular cloning, sequencing, and functional expression of a cDNA encoding human coproporphyrinogen oxidase.

Authors:  P Martasek; J M Camadro; M H Delfau-Larue; J B Dumas; J J Montagne; H de Verneuil; P Labbe; B Grandchamp
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Hepatoerythropoietic porphyria precipitated by viral hepatitis.

Authors:  R J Hift; P N Meissner; G Todd
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

10.  A mouse model of familial porphyria cutanea tarda.

Authors:  J D Phillips; L K Jackson; M Bunting; M R Franklin; K R Thomas; J E Levy; N C Andrews; J P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.